Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioma, particularly high-grade glioma, is aggressive with frequent recurrence and poor patient outcomes.
• The molecular mechanisms driving glioma progression and recurrence are not fully understood.
• Long non-coding RNAs (lncRNAs) are implicated in glioma development, but their role in recurrence remains unclear.

Purpose of the Study:

• To identify differentially expressed long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) in recurrent gliomas compared to primary gliomas.
• To explore the potential functions and regulatory roles of these differentially expressed lncRNAs in glioma recurrence.

Main Methods:

• High-throughput microarray analysis was employed to screen for differentially expressed lncRNAs and mRNAs.
• Gene Ontology (GO) and pathway analyses were performed to understand the functional implications of the identified lncRNAs.
• LncRNA classification and subgroup analysis were conducted to identify potential gene regulatory networks.

Main Results:

• A total of 1,111 lncRNAs were found to be differentially expressed in recurrent gliomas (639 up-regulated, 472 down-regulated).
• Functional analyses indicated that these lncRNAs are associated with cancer progression and pathogenesis.
• Three key clusters of differentially expressed lncRNA-mRNA pairs with potential gene regulatory functions were identified.

Conclusions:

• This study provides the first comprehensive identification of abundant differentially expressed lncRNAs in recurrent gliomas.
• Specific lncRNAs, including known ones like H19 and novel ones like AC016745.3, may be critical drivers of glioma recurrence.
• These findings lay the groundwork for future research into the genetic mechanisms of glioma recurrence and the development of novel therapeutic strategies.